ASO Visual Abstract: Hepatic and Overall Progression-Free Survival After Percutaneous Hepatic Perfusion as First- or Second-Line Therapy for Metastatic Uveal Melanoma.

IF 3.4 2区医学 Q2 ONCOLOGY

Annals of Surgical Oncology Pub Date : 2025-01-01 DOI:10.1245/s10434-024-16307-4

Helana Ghali, Michelle M Dugan, Shaliz Aflatooni, Aleena Boby, Danielle K DePalo, José Laborde, Junsung Choi, Altan F Ahmed, Jonathan S Zager

引用次数: 0

查看原文本刊更多论文

ASO 视觉摘要：经皮肝脏灌注作为转移性葡萄膜黑色素瘤的一线或二线疗法后的肝脏和总体无进展生存期。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Annals of Surgical Oncology 医学-外科

CiteScore

5.90

自引率

10.80%

发文量

1698

审稿时长

2.8 months

期刊介绍： The Annals of Surgical Oncology is the official journal of The Society of Surgical Oncology and is published for the Society by Springer. The Annals publishes original and educational manuscripts about oncology for surgeons from all specialities in academic and community settings.